Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report

Diabetes Care. 2010 Feb;33(2):375-7. doi: 10.2337/dc09-1374. Epub 2009 Nov 16.

Abstract

Objective: To examine after gastric bypass the effect of peroral versus gastroduodenal feeding on glucose metabolism.

Research design and methods: A type 2 diabetic patient was examined on 2 consecutive days 5 weeks after gastric bypass. A standard liquid meal was given on the first day into the bypassed gastric remnant and on the second day perorally. Plasma glucose, insulin, C-peptide, glucagon, incretin hormones, peptide YY, and free fatty acids were measured.

Results: Peroral feeding reduced 2-h postprandial plasma glucose (7.8 vs. 11.1 mmol/l) and incremental area under the glucose curve (iAUC) (0.33 vs. 0.49 mmol . l(-1) . min(-1)) compared with gastroduodenal feeding. beta-Cell function (iAUC(Cpeptide/Glu)) was more than twofold improved during peroral feeding, and the glucagon-like peptide (GLP)-1 response increased nearly fivefold.

Conclusions: Improvement in postprandial glucose metabolism after gastric bypass is an immediate and direct consequence of the gastrointestinal rearrangement, associated with exaggerated GLP-1 release and independent of changes in insulin sensitivity, weight loss, and caloric restriction.

Publication types

  • Case Reports

MeSH terms

  • Area Under Curve
  • Blood Glucose / metabolism*
  • C-Peptide / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / surgery
  • Enteral Nutrition*
  • Fatty Acids, Nonesterified / blood
  • Gastric Bypass*
  • Glucagon / blood
  • Glucagon-Like Peptide 1 / blood
  • Glucagon-Like Peptide 1 / metabolism*
  • Humans
  • Incretins / blood
  • Male
  • Middle Aged
  • Obesity, Morbid / surgery*
  • Peptide YY / blood
  • Postoperative Period*
  • Postprandial Period / physiology*

Substances

  • Blood Glucose
  • C-Peptide
  • Fatty Acids, Nonesterified
  • Incretins
  • Peptide YY
  • Glucagon-Like Peptide 1
  • Glucagon